View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
September 2, 2020updated 07 Sep 2020 7:33am

MedGyn completes Thomas Medical acquisition from Biomerics

US-based medical device supplier and women’s healthcare products developer MedGyn has completed the acquisition of Thomas Medical from Biomerics through one of its subsidiaries.

US-based medical device supplier and women’s healthcare products developer MedGyn has completed the acquisition of Thomas Medical from Biomerics through one of its subsidiaries.

Free Report
img

What’s missing from your IPO industry assessment?

IPO activity all but stopped in 2020, as the investment community grew wary of the effects of COVID-19 on economies. No matter how deserving a business was of flotation, momentum was halted by concerns of when a ‘new normal’ of working patterns and trade would set in. Recently, sentiment has changed. Flotations picked up again during the second half of 2021, and now in 2022 the mood is decidedly optimistic. Business leaders have their eyes on fast rebounding economies, buoyant market indices and the opportunity once again to take their businesses public. As a result, global IPOs are expected to hit back this year. With GlobalData’s new whitepaper, ‘IPOs in Consumer and Retail: 5 must-include elements for your prospectus industry report’, you can explore exactly what is needed in the essential literature. GlobalData’s focus lies in the critical areas to get right:
  • Macroeconomic and demographic environment
  • Consumer context
  • Industry environment
  • Competitive environment
  • Route to market
Interested to learn more about what to include in your IPO Industry Assessment report? Download our free whitepaper.
by GlobalData
Enter your details here to receive your free Report.

The financial terms of the deal were not disclosed.

Based in Indianapolis, US, Thomas Medical develops and manufactures single-use medical devices and accessories, including HS catheters and procedure trays, uterine manipulators (UMI), injectors, endometrial samplers, IUI catheters and LEEP/LLETZ electrodes.

These products are Food and Drug Administration (FDA)-cleared and CE-marked.

MedGyn CEO and chairman Lakshman Agadi said: “This acquisition underscores MedGyn’s strong commitment to both patients and healthcare professionals by continuing to provide trusted products and services in women’s healthcare.

“While we focus on domestic manufacturing, the breadth of our distribution network is global and includes over 140 countries. We look forward to providing our customers with reliable access to Thomas Medical’s high-quality portfolio of products.”

Following the acquisition, Thomas Medical will operate as an independent division of MedGyn. It will retain its brand name and continue to manufacture all products in the US without any disruption.

In a separate development, diagnostic and therapeutic medical technology company Laborie Medical Technologies (LABORIE) has signed an agreement to acquire GI Supply in partnership with growth equity company Signet Healthcare Partners.

GI Supply provides endoscopy and paracentesis products for gastroenterologists, colorectal surgeons and interventional radiologists.

GI Supply, which will continue to operate independently, will be led by its current CEO Kristi Dahlke and its existing leadership team.

LABORIE president and CEO Michael Frazzette said: “At LABORIE, we are committed to helping improve lives by enabling our clinical customers and their patients with relevant solutions for their needs. We do this organically, as well as through strategic acquisitions.

“With the acquisition of GI Supply, we immediately enhance LABORIE’s gastroenterology product offering and sales channel in the US and internationally. This is an important step in the evolution of our GI business.”

Related Companies

Free Report
img

What’s missing from your IPO industry assessment?

IPO activity all but stopped in 2020, as the investment community grew wary of the effects of COVID-19 on economies. No matter how deserving a business was of flotation, momentum was halted by concerns of when a ‘new normal’ of working patterns and trade would set in. Recently, sentiment has changed. Flotations picked up again during the second half of 2021, and now in 2022 the mood is decidedly optimistic. Business leaders have their eyes on fast rebounding economies, buoyant market indices and the opportunity once again to take their businesses public. As a result, global IPOs are expected to hit back this year. With GlobalData’s new whitepaper, ‘IPOs in Consumer and Retail: 5 must-include elements for your prospectus industry report’, you can explore exactly what is needed in the essential literature. GlobalData’s focus lies in the critical areas to get right:
  • Macroeconomic and demographic environment
  • Consumer context
  • Industry environment
  • Competitive environment
  • Route to market
Interested to learn more about what to include in your IPO Industry Assessment report? Download our free whitepaper.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network